Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...

This guide describes how to move highlighted cells in Excel in Windows 11/10 using drag and drop, cut and paste, and other ...

The masses have long tried to emulate legendary investors in the hopes of capturing some of their returns. Copy trading, also ...

Participation in the reactor pilot program gives us access to a Department of Energy authorization pathway aligning our ...

Earlier this afternoon, BioAtla, Inc. released financial results and a business update for the quarter ended 09/30/2025.

PROPOSED LISTING OF CELL C HOLDINGS LIMITED ON THE MAIN BOARD OF THE JSE LIMITED AND ABRIDGED PRE-LISTING STATEMENT THE ABRIDGED PRE-LISTING STATEMENT DOES NOT CONSTITUTE AN OFFER TO ANY PERSON IN ANY ...